APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimalarial Medication

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antimalarial Medication Market Outlook and Growth Opportunities 2026

20 December 2025191 pages

Choose your research edition.

Industry ResearchAntimalarial Medication Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimalarial Medication Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Antimalarial Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimalarial Medication Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimalarial Medication Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Antimalarial Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antimalarial Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antimalarial Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antimalarial Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antimalarial Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antimalarial Medication market include Sun Pharmaceutical Industries, Novartis, Merck, Pfizer, GlaxoSmithKline and F. Hoffmann-La Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antimalarial Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antimalarial Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antimalarial Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antimalarial Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Antimalarial Medication Segment by Company

Sun Pharmaceutical Industries

Novartis

Merck

Pfizer

GlaxoSmithKline

F. Hoffmann-La Roche

Antimalarial Medication Segment by Type

Plasmodium Malariae

Plasmodium Ovale

Plasmodium Vivax

Plasmodium Falciparum

Antimalarial Medication Segment by Application

E- Commerce

Retail Pharmacy

Hospital Pharmacy

Others

Antimalarial Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Antimalarial Medication status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antimalarial Medication market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antimalarial Medication significant trends, drivers, influence factors in global and regions.

6. To analyze Antimalarial Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimalarial Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimalarial Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimalarial Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antimalarial Medication market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antimalarial Medication industry.

Chapter 3: Detailed analysis of Antimalarial Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antimalarial Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antimalarial Medication in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antimalarial Medication Industry Trends Table 2. Antimalarial Medication Industry Drivers Table 3. Antimalarial Medication Industry Opportunities and Challenges Table 4. Antimalarial Medication Industry Restraints Table 5. Global Antimalarial Medication Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antimalarial Medication Revenue Share by Company (2021-2026) Table 7. Global Antimalarial Medication Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Antimalarial Medication Sales Volume Share by Company (2021-2026) Table 9. Global Antimalarial Medication Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Antimalarial Medication Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antimalarial Medication Key Company Manufacturing Base & Headquarters Table 12. Global Antimalarial Medication Company, Product Type & Application Table 13. Global Antimalarial Medication Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antimalarial Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plasmodium Malariae Table 18. Significant Companies of Plasmodium Ovale Table 19. Significant Companies of Plasmodium Vivax Table 20. Significant Companies of Plasmodium Falciparum Table 21. Global Antimalarial Medication Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Antimalarial Medication Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Antimalarial Medication Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Antimalarial Medication Sales Volume Share by Type (2021-2026) Table 25. Global Antimalarial Medication Sales Volume Share by Type (2027-2032) Table 26. Global Antimalarial Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Antimalarial Medication Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Antimalarial Medication Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Antimalarial Medication Sales Value Share by Type (2021-2026) Table 30. Global Antimalarial Medication Sales Value Share by Type (2027-2032) Table 31. Significant Companies of E- Commerce Table 32. Significant Companies of Retail Pharmacy Table 33. Significant Companies of Hospital Pharmacy Table 34. Significant Companies of Others Table 35. Global Antimalarial Medication Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Antimalarial Medication Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Antimalarial Medication Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Antimalarial Medication Sales Volume Share by Application (2021-2026) Table 39. Global Antimalarial Medication Sales Volume Share by Application (2027-2032) Table 40. Global Antimalarial Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Antimalarial Medication Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Antimalarial Medication Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Antimalarial Medication Sales Value Share by Application (2021-2026) Table 44. Global Antimalarial Medication Sales Value Share by Application (2027-2032) Table 45. Global Antimalarial Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Antimalarial Medication Sales by Region (2021-2026) & (K Units) Table 47. Global Antimalarial Medication Sales Market Share by Region (2021-2026) Table 48. Global Antimalarial Medication Sales by Region (2027-2032) & (K Units) Table 49. Global Antimalarial Medication Sales Market Share by Region (2027-2032) Table 50. Global Antimalarial Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Antimalarial Medication Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Antimalarial Medication Sales Value Share by Region (2021-2026) Table 53. Global Antimalarial Medication Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Antimalarial Medication Sales Value Share by Region (2027-2032) Table 55. Global Antimalarial Medication Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Antimalarial Medication Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Antimalarial Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Antimalarial Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 60. Global Antimalarial Medication Sales Market Share by Country (2021-2026) Table 61. Global Antimalarial Medication Sales by Country (2027-2032) & (K Units) Table 62. Global Antimalarial Medication Sales Market Share by Country (2027-2032) Table 63. Global Antimalarial Medication Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Antimalarial Medication Sales Value Market Share by Country (2021-2026) Table 65. Global Antimalarial Medication Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Antimalarial Medication Sales Value Market Share by Country (2027-2032) Table 67. Sun Pharmaceutical Industries Company Information Table 68. Sun Pharmaceutical Industries Business Overview Table 69. Sun Pharmaceutical Industries Antimalarial Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sun Pharmaceutical Industries Antimalarial Medication Product Portfolio Table 71. Sun Pharmaceutical Industries Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Antimalarial Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis Antimalarial Medication Product Portfolio Table 76. Novartis Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Antimalarial Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Antimalarial Medication Product Portfolio Table 81. Merck Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Antimalarial Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Pfizer Antimalarial Medication Product Portfolio Table 86. Pfizer Recent Development Table 87. GlaxoSmithKline Company Information Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Antimalarial Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline Antimalarial Medication Product Portfolio Table 91. GlaxoSmithKline Recent Development Table 92. F. Hoffmann-La Roche Company Information Table 93. F. Hoffmann-La Roche Business Overview Table 94. F. Hoffmann-La Roche Antimalarial Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. F. Hoffmann-La Roche Antimalarial Medication Product Portfolio Table 96. F. Hoffmann-La Roche Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Antimalarial Medication Distributors List Table 100. Antimalarial Medication Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Antimalarial Medication Product Image Figure 2. Global Antimalarial Medication Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimalarial Medication Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antimalarial Medication Sales (2021-2032) & (K Units) Figure 5. Global Antimalarial Medication Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Antimalarial Medication Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plasmodium Malariae Image Figure 10. Plasmodium Ovale Image Figure 11. Plasmodium Vivax Image Figure 12. Plasmodium Falciparum Image Figure 13. Global Antimalarial Medication Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Antimalarial Medication Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Antimalarial Medication Sales Volume Share by Type (2021-2032) Figure 16. Global Antimalarial Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Antimalarial Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Antimalarial Medication Sales Value Share by Type (2021-2032) Figure 19. E- Commerce Image Figure 20. Retail Pharmacy Image Figure 21. Hospital Pharmacy Image Figure 22. Others Image Figure 23. Global Antimalarial Medication Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Antimalarial Medication Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Antimalarial Medication Sales Volume Share by Application (2021-2032) Figure 26. Global Antimalarial Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antimalarial Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Antimalarial Medication Sales Value Share by Application (2021-2032) Figure 29. Global Antimalarial Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Antimalarial Medication Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Antimalarial Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Antimalarial Medication Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Antimalarial Medication Sales Value (2021-2032) & (US$ Million) Figure 34. North America Antimalarial Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Antimalarial Medication Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Antimalarial Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Antimalarial Medication Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Antimalarial Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Antimalarial Medication Sales Value (2021-2032) & (US$ Million) Figure 40. South America Antimalarial Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Antimalarial Medication Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Antimalarial Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Antimalarial Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Antimalarial Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Antimalarial Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Antimalarial Medication Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Antimalarial Medication Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmodium Malariae
  • Plasmodium Ovale
  • Plasmodium Vivax
  • Plasmodium Falciparum
Applications
  • E- Commerce
  • Retail Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • F. Hoffmann-La Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antimalarial Medication Sales Value (2021-2032)
  4. 1.2.2 Global Antimalarial Medication Sales Volume (2021-2032)
  5. 1.2.3 Global Antimalarial Medication Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antimalarial Medication Market Dynamics
  1. 2.1 Antimalarial Medication Industry Trends
  2. 2.2 Antimalarial Medication Industry Drivers
  3. 2.3 Antimalarial Medication Industry Opportunities and Challenges
  4. 2.4 Antimalarial Medication Industry Restraints
3 Antimalarial Medication Market by Company
  1. 3.1 Global Antimalarial Medication Company Revenue Ranking in 2025
  2. 3.2 Global Antimalarial Medication Revenue by Company (2021-2026)
  3. 3.3 Global Antimalarial Medication Sales Volume by Company (2021-2026)
  4. 3.4 Global Antimalarial Medication Average Price by Company (2021-2026)
  5. 3.5 Global Antimalarial Medication Company Ranking (2024-2026)
  6. 3.6 Global Antimalarial Medication Company Manufacturing Base and Headquarters
  7. 3.7 Global Antimalarial Medication Company Product Type and Application
  8. 3.8 Global Antimalarial Medication Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antimalarial Medication Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antimalarial Medication Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antimalarial Medication Market by Type
  1. 4.1 Antimalarial Medication Type Introduction
  2. 4.1.1 Plasmodium Malariae
  3. 4.1.2 Plasmodium Ovale
  4. 4.1.3 Plasmodium Vivax
  5. 4.1.4 Plasmodium Falciparum
  6. 4.2 Global Antimalarial Medication Sales Volume by Type
  7. 4.2.1 Global Antimalarial Medication Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Antimalarial Medication Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Antimalarial Medication Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Antimalarial Medication Sales Value by Type
  11. 4.3.1 Global Antimalarial Medication Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Antimalarial Medication Sales Value by Type (2021-2032)
  13. 4.3.3 Global Antimalarial Medication Sales Value Share by Type (2021-2032)
5 Antimalarial Medication Market by Application
  1. 5.1 Antimalarial Medication Application Introduction
  2. 5.1.1 E- Commerce
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Antimalarial Medication Sales Volume by Application
  7. 5.2.1 Global Antimalarial Medication Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antimalarial Medication Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Antimalarial Medication Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Antimalarial Medication Sales Value by Application
  11. 5.3.1 Global Antimalarial Medication Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antimalarial Medication Sales Value by Application (2021-2032)
  13. 5.3.3 Global Antimalarial Medication Sales Value Share by Application (2021-2032)
6 Antimalarial Medication Regional Sales and Value Analysis
  1. 6.1 Global Antimalarial Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antimalarial Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Antimalarial Medication Sales by Region: 2021-2026
  4. 6.2.2 Global Antimalarial Medication Sales by Region (2027-2032)
  5. 6.3 Global Antimalarial Medication Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antimalarial Medication Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antimalarial Medication Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antimalarial Medication Sales Value by Region (2027-2032)
  9. 6.5 Global Antimalarial Medication Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antimalarial Medication Sales Value (2021-2032)
  12. 6.6.2 North America Antimalarial Medication Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antimalarial Medication Sales Value (2021-2032)
  15. 6.7.2 Europe Antimalarial Medication Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antimalarial Medication Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antimalarial Medication Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antimalarial Medication Sales Value (2021-2032)
  21. 6.9.2 South America Antimalarial Medication Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antimalarial Medication Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antimalarial Medication Sales Value Share by Country, 2025 VS 2032
7 Antimalarial Medication Country-level Sales and Value Analysis
  1. 7.1 Global Antimalarial Medication Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antimalarial Medication Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antimalarial Medication Sales by Country (2021-2032)
  4. 7.3.1 Global Antimalarial Medication Sales by Country (2021-2026)
  5. 7.3.2 Global Antimalarial Medication Sales by Country (2027-2032)
  6. 7.4 Global Antimalarial Medication Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antimalarial Medication Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antimalarial Medication Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antimalarial Medication Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antimalarial Medication Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antimalarial Medication Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antimalarial Medication Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antimalarial Medication Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antimalarial Medication Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antimalarial Medication Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antimalarial Medication Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antimalarial Medication Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antimalarial Medication Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antimalarial Medication Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antimalarial Medication Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antimalarial Medication Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antimalarial Medication Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antimalarial Medication Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antimalarial Medication Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antimalarial Medication Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antimalarial Medication Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antimalarial Medication Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antimalarial Medication Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antimalarial Medication Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antimalarial Medication Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antimalarial Medication Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antimalarial Medication Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antimalarial Medication Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antimalarial Medication Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antimalarial Medication Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antimalarial Medication Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antimalarial Medication Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antimalarial Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Antimalarial Medication Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Antimalarial Medication Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Antimalarial Medication Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Antimalarial Medication Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Antimalarial Medication Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Antimalarial Medication Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Antimalarial Medication Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Antimalarial Medication Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Antimalarial Medication Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 F. Hoffmann-La Roche
  32. 8.6.1 F. Hoffmann-La Roche Company Information
  33. 8.6.2 F. Hoffmann-La Roche Business Overview
  34. 8.6.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 F. Hoffmann-La Roche Antimalarial Medication Product Portfolio
  36. 8.6.5 F. Hoffmann-La Roche Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antimalarial Medication Value Chain Analysis
  2. 9.1.1 Antimalarial Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antimalarial Medication Sales Mode & Process
  6. 9.2 Antimalarial Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antimalarial Medication Distributors
  9. 9.2.3 Antimalarial Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst